January 22, 2019New Haven, Conn. — Yale Cancer Center (YCC) is proud to announce the Basser BRCA Initiative grant. The $1 million, three-year gift was awarded to YCC by the Gray Foundation to advance the next generation of cancer therapies. Leveraging research currently being done at Yale to define the fundamental biology and molecular roles of the BRCA cancer susceptibility genes, this gift from the Gray Foundation will enable the development of transformative new therapeutic approaches for patients with BRCA-driven malignancies, which can increase the lifetime risk for cancers including breast, ovarian, pancreatic, prostate and melanoma.